|
参考文献一覧
The Lindesmith Center
Lynn Zimmer, John P. Morgan
http://www.druglibrary.org/schaffer/hemp/general/mjmyth/Exposing_notes_1095.html
1. Grinspoon, L., Marihuana Reconsidered,
Cambridge: University of Harvard Press (1971); Kaplan, J., Marijuana: The
New Prohibition, New York: World Publishing Company 1970); Brecher, E.M., Licit
and Illicit Drugs, Boston: Little, Brown and Company (1972).
2. U.S. National Commission on Marijuana and Drug Abuse, Marijuana:
A Signal of Misunderstanding, Washington, DC: U.S. Government Printing
Office (1972); Canadian Government's Commission of Inquiry, The Non-Medical
Use of Drugs: Interim Report, Ottawa (1970).
3. Himmelstein, J., The Strange Career of Marijuana:
Politics and Ideology of Decriminalization in America, Westport, CT:
Greenwood Press (1983); Single, E.W., "The Impact of Marijuana
Decriminalization: An Update," Journal of Public Health Policy
10:456-66 (1989).
4. Carter, W.E. (ed), Cannabis in Costa Rica: A Study of
Chronic Marijuana Use, Philadelphia: Institute for Study of Human Issues
(1980); Rubin, V. and Comitas, L., Ganja in Jamaica, The Hague: Mouton
(1975); Stefanis, C. et al, Hashish: Studies of Long Term Use, New
York: Raven Press (1977).
5. Preliminary Estimates From the 1993 National
Household Survey on Drug Abuse, Rockville, MD: U.S. Department of Health
and Human Services (1994).
6. Johnston, L.D. et al, Monitoring the Future, Ann
Arbor: University of Michigan Institute for Social Research (1994).
7. Ennett, S.T, et al, "How Effective is Drug Abuse
Resistance Education? A Meta-Analysis of Project DARE Outcome Evaluations,"
American Journal of Public Health 84:1394-1401 (1994).
8. ElSohly, M.A. et al, "Constituents of Cannabis
Sativa L XXIV: The Potency of Confiscated Marijuana, Hashish, and Hash Oil Over
a Ten-year Period," Journal of Forensic Sciences 29:500-14 (1984).
9. Perry, D., "Street Drug Analysis and Drug Use
Trends, Part II, 1969-1976," PharmChem Newsletter 6 (1977).
10. Rubin, V., "Cross-Cultural Perspectives on
Therapeutic Uses of Cannabis," pp 1-18 in S. Cohen and R.C. Stillman (eds),
The Therapeutic Potential of Marijuana, New York: Plenum Medical Book
Company (1976).
11. Chang, A.E. et al, "Delta-Nine-Tetrahydrocannabinol
as an Antiemetic in Cancer Patients Receiving High-Dose Methotrexate: A
Prospective Randomized Evaluation, Annals of Internal Medicine 91:
819-24 (1979).
12.Hepler, R.S. and Frank, I.R., "Marijuana Smoking and
Intracular Pressure," Journal of the American Medical Association
217: 1392 (1971).
13. Petro, D.J., "Marijuana as a Therapeutic Agent for
Muscle Spasm or Spasticity," Psychosomatics 21: 81-85 (1980).
14. Grinspoon, L. and Bakalar, J.B, Marihuana: The
Forbidden Medicine, New Haven: Yale University Press (1993).
15. Vinciguerra, V. et al, "Inhalation Marijuana as an
Antiemetic for Cancer Chemotherapy," New York State Journal of Medicine
85:525-27 (1988); Dansac, D., "In the Matter of Marijuana Rescheduling
Petition," Affidafit filed in Drug Enforcement Adminstration Hearings,
Docket 86-22 (1987).
16. Doblin, R. and Kleiman, M.A.R., "Marijuana as an
Anti-Emetic Medicine: A Survey of Oncologists' Attitudes and Experiences," Journal
of Clinical Oncology 19: 1275-1290 (1991).
17. Agurell, S. et al, "Pharmacokinetics and Metabolism
of Delta-1-Tetrahydrocannabinol and Other Cannabinoids with Emphasis on
Man," Pharmacological Reviews 38: 21-43 (1986).
18. Cohen, S., "Therapeutic Aspects," pp 194-225
in R.C. Petersen (ed) Marijuana Research Findings: 1976, Rockville, MD:
National Institute on Drug Abuse (1977); Cohen, S. and Stillman, R.C. (eds), The
Therapeutic Potential of Marijuana, New York: Plenum Medical Book Company
(1976); National Institute on Drug Abuse, Marijuana and Health, Report
to Congress (1980).
19. "Members of Congress Voice Support for
Marijuana/AIDS Research," Newsletter of the Multidisciplinary
Association for Psychedelic Studies 5,3 (Winter 1995).
20. Drug Enforcement Administration, Drug Legalization:
Myths and Misconceptions, Washington, DC: U.S. Department of Justice
(1994).
21. Huber, G.L. et al, "The Effects of Marihuana on the
Respiratory and Cardiovascular Systems," pp 3-18 in G. Chesher et al (eds),
Marijuana: an International Research Report, Canberra: Australian
Government Publishing Service (1988).
22. Tashkin, D.P. et al, "Longitudinal Changes in
Respiratory Symptoms and Lung Function in Non-smokers, Tobacco Smokers, and
Heavy, Habitual Smokers of Marijuana With or Without Tobacco," pp 25-36 in
G. Chesher et al (eds), Marijuana: an International Research Report,
Canberra: Australian Government Publishing Service (1988).
23. Sherrill, D.L. et al, "Respiratory Effects of
Non-Tobacco Cigarettes: A Longitudinal Study in General Population," International
Journal of Epidemiology 20: 132-37 (1991).
24. Fligiel, S.E.G. et al, "Bronchial Pathology in
Chronic Marijuana Smokers: A Light Electron Microscope Study," Journal
of Psychoactive Drugs 20:33-42 (1988).
25. Doblin, R., "The MAPS/California NORML/Marijuana
Waterpipe/Vaporizer Study," Newsletter of the Multidisciplinary
Association for Psychedelic Studies 5,1 (Summer 1994).
26. Nahas, G.G. et al, "Inhibition of Cellular Mediated
Immunity in Marijuana Smokers," Science 183:419-20 (1974).
27. Lau, R.J. et al, "Phytohemagglutinin-Induced
Lymphocyte Transformation in Humans Receiving
Delta-9-Tetrahydrocannabinol," Science 192: 805-07 (1976); White,
S.C. et al, "Mitogen-Induced Blastogenetic Responses to Lymphocytes from
Marijuana Smokers," Science 188: 71-72 (1975).
28. Wallace, J.M. et al, "Peripheral Blood Lymphocyte
Subpopulations and Mitogen Responsiveness in Tobacco and Marijuana
Smokers," Journal of Psychoactive Drugs 20:9-14 (1988).
29. Mishkin, E.M. and Cabral, G.A.,
"Delta-9-Tetrahydrocannabinol Decreases Host Resistance to Herpes Simplex
Virus Type 2 Vaginal Infection in the BGC3F1 Mouse," Journal of General
Virology 66:2539-49 (1985).
30. Carter, W.E. (ed), Cannabis in Costa Rica: A Study
of Chronic Marijuana Use, Philadelphia: Institute for Study of Human Issues
(1980); Rubin, V. and Comitas, L., Ganja in Jamaica, The Hague: Mouton (1975);
Stefanis, C. et al, Hashish: Studies of Long Term Use, New York: Raven Press
(1977).
31. Coates, R.A. et al, "Cofactors of Progression to
Acquired Immunodeficiency Syndrome in a Cohort of Male Sexual Contacts of Men
with Immunodeficiency Virus Disease," American Journal of Epidemiology 132:
717-22 (1990).
32. Plasse, T.F. et al, "Recent Clinical Experience
with Dronabinol," Pharmacology Biochemistry and Behavior
40:695-700 (1991).
33. Lynn, A.B. and Herkenham, M., "Localization of
Cannabinoid Receptors and Nonsaturable High Density Cannabinoid Binding Sites in
Peripheral Tissues of the Rat: Implications for Receptor-Mediated Immune
Modulation by Cannabinoids," Journal of Pharmacology and Experimental
Therapeutics 268: 1612-23 (1994).
34. Kolodny, R.C. et al, "Depression of Plasma
Testosterone Levels After Chronic Intensive Marijuana Use," New England
Journal of Medicine 290:872-74 (1974).
35. Kolodny, R.C. et al, "Depression of Plasma
Testosterone with Acute Marijuana Administration," pp 217-25 in M.C. Braude
and S. Szara (eds), Pharmacology of Marijuana, New York: Raven Press
(1976).
36. Mendelson, G.D. et al, "Plasma Testosterone Levels
Before, During, and After Chronic Marijuana Smoking," New England
Journal of Medicine 291:1051-55 (1975); Schaefer, C.F. et al, "Normal
Plasma Testosterone Concentrations After Marijuana Smoking," New
England Journal of Medicine 292:867-68 (1975).
37. Hembree, W.C. et al, "Changes in Human Spermatozoa
Associated with High Dose Marijuana Smoking," pp 429-39 in G.G. Nahas and
W.D.M. Paton (eds), Marijuana: Biological Effects, Oxford: Pergamon
Press (1979).
38. Fijimoto, G.I. et al, "Effect of Marijuana Extract
Given Orally on Male Rat Reproduction and Gonads," Proceedings of Sixth
Annual Meetings of Endocrinology Society (1978); Okey, A.B. and Truant, G.S.,
"Cannabis Demasculinizes Rats But Is Not Estrogenic," Life
Sciences 17:1113-18 (1975).
39. Block, R.I. et al, "Effects of Chronic Marijuana
Use on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone,
Prolactin and Cortisol in Men and Women," Drug and Alcohol Dependence
28:121-8 (1991).
40. Smith, C.G. and Asch, R.H., "Acute, Short-Term, and
Chronic Effects of Marijuana on the Female Primate Reproductive Function,"
pp 82-96 in M.C. Braude and J.P. Ludford (eds), Marijuana Effects on the
Endocrine and Reproductive Systems, Rockville, MD: Department of Health and
Human Services (1984).
41. Smith, C.G. et al, "Tolerance Develops to the
Disruptive Effects of Delta 9 Tetrahydrocannabinol on the Primate Menstrual
Cycle," Science 219:1453-55 (1983).
42. Copeland, K.C. et al, "Marijuana Smoking and
Pubertal Arrest," Journal of Pediatrics 96:1079-80 (1980).
43. Tennes, A., "Effects of Marijuana on Pregnancy and
Fetal Development in the Human," pp 115-23 in M.C. Braude and J. P, Ludford
(eds), Marijuana Effects on the Endocrine and Reproductive Systems,
Rockville, MD: Department of Health and Human Services (1984).
44. Astley, S., "Analysis of Facial Shape in Children
Gestationally Exposed to Marijuana, Alcohol, and/or Cocaine," Pediatrics
89:67-77 (1992); Day, N. et al, "Prenatal Marijuana Use and Neonatal
Outcome," Neurotoxicology and Teratology 13:329-34 (1992); Linn,
S. et al, "The Association of Marijuana Use with Outcome of
Pregnancy," American Journal of Public Health 73:1161-64 (1983).
45. Hayes, J. et al, "Newborn Outcomes with Maternal
Marijuana Use in Jamaican Women," Pediatric Nursing 14(2):107-10
(1988); Streissguth, A.P. et al, "IQ at Age 4 in Relation to Maternal
Alcohol Use and Smoking During Pregnancy," Developmental Psychology
25: 3-11 (1989); Richardson, G.A. et al, "The Effect of Prenatal Alcohol,
Marijuana and Tobacco Exposure on Neonatal Behavior," Infant Behavioral
Development 12: 199-209 (1989); O'Connell, C.M. and Fried, P.A.,
"Prenatal Exposure to Cannabis: A Preliminary Report of Postnatal
Consequences in School-Age Children," Neurotoxicology and Teratology
13: 631-39 (1991); Fried, P.A. et al, "60- and 72-Month Follow-Up of
Children Prenatally Exposed to Marijuana, Cigarettes and Alcohol," Journal
of Developmental Behavior and Pediatrics 13: 383-91 (1992); Dreher, M.C. et
al, "Prenatal Exposure and Neonatal Outcomes in Jamaica: An Ethnographic
Study," Pediatrics 93: 254-60 (1994).
46. Buckley, J.D. et al, "Occupational Exposure of
Parents of Children with Acute Nonlymphocytic Leukemia: A Report from the
Children's Cancer Study Group," Cancer Research 49:4030-37 (1989).
47. Fried, P.A., "Postnatal Consequences of Maternal
Marijuana Use," pp 61-72 in T.M. Pinkert (ed), Current Research on the
Consequences of Maternal Drug Abuse, Rockville, MD: National Institute on
Drug Abuse; Fried, P.A. and B. Watkinson, "12- and 24-Month Neurobehavioral
Follow-Up of Children Prenatally Exposed to Marijuana, Cigarettes and
Alcohol," Neurotoxicology and Teratology 10: 305-13 (1988)
48. Fried, P.A. and B. Watkinson, "36- and 48-Month
Neurobehavioral Follow-Up of Children Prenatally Exposed to Marijuana,
Cigarettes, and Alcohol," Developmental and Behavioral Pediatrics11:
49-58 (1990).
49. Fried, P.A. et al, "A Follow-Up Study of
Attentional Behavior in 6-Year-Old Children Exposed Prenatally to Marijuana,
Cigarettes, and Alcohol," Neurotoxicology and Teratology 14:
299-311 (1992).
50. Day, N.L. et al, "Effect of Prenatal Marijuana
Exposure on the Cognitive Development of Offspring at Age Three," Neurotoxicology
and Teratology 16: 169-75 (1994).
51. Heath, B.C. et al, "Cannabis Sativa: Effects on
Brain Function and Ultrastructure in Rhesus Monkeys," Biological
Psychiatry 15:657 (1980).
52. Scallet, A.C., "Neurotoxicology of Cannabis and
THC: A Review of Chronic Exposure Studies in Animals," Pharmacology
Biochemistry and Behavior 40:671-82 (1991).
53. Slikker, W. et al, "Behavioral, Neurochemical, and
Neurohistological Effects of Chronic Marijuana Smoke Exposure in the Nonhuman
Primate," pp 219-74 in L. Murphy and A. Bartke (eds), Marijuana/Cannabinoids
Neurobiology and Neurophysiology, Boca Raton: CRC Press (1992).
54. Weckowicz, T.E. et al, "Effect of Marijuana on
Divergent and Convergent Production Cognitive Tests," Journal of
Abnormal Psychology 84:386-98 (1975); Hooker, W.D., and Jones, R.T.,
"Increased Susceptibility to Memory Intrusions and the Stroop Interference
Effect During Acute Marijuana Intoxication," Psychopharmacology 91:
20-24 (1987); Waskow, I.E. et el, "Psychological Effects of
Tetrahydrocannabinol," Archives of General Psychiatry 22: 97-107
(1970); Dornbush, R.L. and Kokkevi, A., "Acute Effects of Cannabis on
Cognitive, Perceptual, and Motor Performance in Chronic Hashish Users," Annals
of the New York Academy of Sciences 282: 213-22 (1976).
55. Darley, C.F. et al, "Marijuana Effects on Long-Term
Memory Assessment and Retrieval," Psychopharmacology 52:239-41
(1977); Abel, E.L., "Retrieval of Information After Use of Marijuana,"
pp 121-24 in E.L. Abel (ed) The Scientific Study of Marijuana, Chicago:
Nelson-Hall Publishers (1976); Abel, E.L., "Marijuana and Memory:
Acquisition or Retrieval?" pp 125-32 in E.L. Abel (ed) The Scientific
Study of Marijuana, Chicago: Nelson-Hall Publishers (1976).
56. Abel, E.L., "Marijuana and Memory: Acquisition or
Retrieval?" pp 125-32 in E.L. Abel (ed) The Scientific Study of
Marijuana, Chicago: Nelson-Hall Publishers (1976); Miller, L. et al,
"Effects of Marijuana on Recall of Narrative Material and Stroop Colour-Word
Performance," pp 117-20 in E.L. Abel (ed) The Scientific Study of
Marijuana, Chicago: Nelson-Hall Publishers (1976); Dornbush, R.L. et al,
"Marijuana, Memory, and Perception," pp 133-40 in E.L. Abel (ed) The
Scientific Study of Marijuana, Chicago: Nelson-Hall Publishers (1976).
57. Ferraro, D.P., "Acute Effects of Marijuana on Human
Memory and Cognition," pp 98-119 in R.C. Petersen (ed) Marijuana
Research Findings: 1980, Rockville, MD: National Institute on Drug Abuse
(1980).
58. Satz, P. et al, "Neuropsychologic, Intellectual,
and Personality Correlates of Chronic Marijuana Use in Native Costa
Ricans," Annals of the New York Academy of Sciences 282: 266-306
(1976); Grant, I. et al, "A Neuropsychological Assessment of the Effects of
Moderate Marijuana Use," Journal of Nervous and Mental Disease
156: 278-80 (1973); Knights, R., "Psychological Test Results," pp
111-20 in V. Rubin and L. Comitas (eds), Ganja in Jamaica, The Hague:
Mouton (1975); Page, J.B., "Psychosociocultural Perspectives on Chronic
Cannabis Use: The Costa Rican Follow-Up," Journal of Psychoactive Drugs
20: 57-65 (1988); Carlin, A.S. and Trupin, E.W., "The Effect of Long-Term
Chronic Marijuana Use on Neuropsychological Functioning," International
Journal of the Addictions 12:617-24 (1977).
59. Preliminary Estimates from the 1993 National
Household Survey on Drug Abuse, Rockville, MD: U.S. Department of Health
and Human Services (1994).
60. Johnston, L.D. et al, Drug Use Among American High
School Seniors, College Students and Young Adults, 1975-1990,Vol II,
Rockville, MD: U.S. Department of Health and Human Services (1991), p 31.
61. Jones, R.T. et al, "Clinical Studies of Cannabis
Tolerance and Dependence," Annals of the New York Academy of Sciences
282:221-39 (1976).
62. Stefanis. C. et al, "Experimental Observations of a
3-Day Hashish Abstinence Period and Reintroduction of Use," Annals of
the New York Academy of Sciences 282:113-20 (1976); Cohen, S. et al,
"The 94-Day Study," pp 621-26 in M.C. Braude and S. Szara (eds), The
Pharmacology of Marijuana, New York: Raven Press (1976).
63. Deneau, G.A. and Kaymakcalan, S., "Physiological
and Psychological Dependence to Synthetic Delta-9-Tetrahydrocannabinol (THC) in
Rhesus Monkeys," Pharmacologist13:246 (1971).
64. Martin, B.R., "Marijuana: What It Is and What It
Does," Presentation at NIDA's National Conference on Marijuana Use
Prevention, Treatment and Research," Arlington, VA (July 1995).
65. Gold, M.S., The Good News About Drugs and Alcohol,
New York: Villard Books (1991).
66. Jacobs, J.B. and Zimmer, L., "Drug Treatment and
Workplace Drug Testing: Politics, Symbolism and Organizational Dilemmas," Behavioral
Sciences and the Law 9:345-60 (1991).
67. Annual Emergency Room Data, 1990, National
Institute on Drug Abuse Statistical Series, Series I, Number 10-A, Rockville,
MD: National Institute on Drug Abuse (1991); Annual Emergency Room Data,
1992, National Institute on Drug Abuse Statistical Series, Series I, Number
12-A, Rockville, MD: National Institute on Drug Abuse (1993); Preliminary
Estimates from the Drug Abuse Warning Network, Advance Report Number 8,
Rockville, MD: National Institute on Drug Abuse (1994).
68. McGlothlin, H.W. and West, L.J., "The Marijuana
Problem: An Overview," American Journal of Psychiatry 125:1126-34
(1968); Smith, D.E., "The Acute and Chronic Toxicity of Marijuana," Journal
of Psychedelic Drugs 2:37-48 (1968).
69. Brill, N.O. and Christie, R.L., "Marijuana Use and
Psychosocial Adaptation," Archives of General Psychiatry 31:713-19
(1974); Kupfer, D.J. et al, "A Comment on the Amotivational Syndrome in
Marijuana Smokers," American Journal of Psychiatry 130:1319-22
(1973).
70. Kleinman, P.H. et al, "Daily Marijuana Use and
Problem Behaviors Among Adolescents," International Journal of
Addictions 23:87-107 (1988).
71. Mellinger, G.D. et al, "Drug Use, Academic
Performance, and Career Indecision: Longitudinal Data in Search of a
Model," pp 157-77 in D.B. Kandel (ed), Longitudinal Research on Drug
Use: Empirical Findings and Methodological Issues, Washington, DC:
Hemisphere (1978).
72. Mellinger, G.D. et al, "The Amotivational Syndrome
and the College Student," Annals of the New York Academy of Sciences 282:37-55 (1976).
73. Miranne. H.C., "Marijuana Use and Achievement
Orientations of College Students," Journal of Health and Social
Behavior 20:194-99 (1979).
74. Cohen, S., "The 94-Day Cannabis Study," Annals
of the New York Academy of Sciences 282:211-20 (1976).
75. Mendelson, J.H. et al, "The Effects of Marijuana
Use on Human Operant Behavior: Individual Data," pp 643-53 in M.C. Braude
and S. Szara (eds), The Pharmacology of Marijuana, Vol 2, New York:
Raven Press (1976).
76. Campbell, I., "The Amotivational Syndrome and
Cannabis use with Emphasis on the Canadian Scene," Annals of the New
York Academy of Sciences 282:33-36.
77. McBay, A.J. and Owens, S.M., "Marijuana and
Driving," pp 257-63 in L.S. Harris (ed) Problems of Drug Dependence
1980, Washington, DC: U.S. Government Printing Office (1981); Teale, J.D. et al,
"The Incidence of Cannabinoids in Fatally Impaired Drivers: An
Investigation by Radioimmunoassay and High Pressure Liquid Chromatography,"
Journal of the Forensic Science Society 17:177-83 (1978).
78. Terhune, K.W. et al, The Incidence and Role of Drugs
in Fatally Injured Drivers, Washington, DC: Department of Transportation
(1994).
79. Brookoff, D. et al, "Testing Reckless Drivers for
Cocaine and Marijuana," New England Journal of Medicine 331:518-22
(1994).
80. Kv'alseth, T.O., "Effects of Marijuana on Human
Reaction Time and Motor Control," Perceptual and Motor Skills
45:935-39 (1977); Hansteen, R.W. et al, "Effects of Cannabis and Alcohol on
Automobile Driving and Psychomotor Tracking," Annals of New York
Academy of Sciences 282:240-56 (1976); Moskowitz, H. et al,
"Marijuana: Effects on Simulated Driving Performance," Accident
Analysis and Prevention 8:45-50 (1976); Moskowitz, H. et al, "Visual
Search Behavior While Viewing Driving Scenes Under the Influence of Alcohol and
Marijuana," Human Factors 18:417-31 (1976).
81. Stein, A.C. et al, A Simulator Study of the Combined
Effects of Alcohol and Marijuana on Driving Behavior-Phase II, Washington,
DC: U.S. Department of Transportation (1983).
82. Robbe, H. and O'Hanlon, J., Marijuana and Actual
Driving Performance, Washington, DC: Department of Transportation (1993).
83. U.S. Department of Health and Human Services, National
Household Survey on Drug Abuse: Main Findings 1990; U.S. Department of
Health and Human Services, Preliminary Estimates from the 1993 National
Household Survey on Drug Abuse.
84. Johnston, L.D. et al, Monitoring the Future,
Ann Arbor: University of Michigan Institute for Social Research (1994).
85. Cohen, P.D.A., Cannabisgebruikers in Amsterdam,
Jaarbeurs Congrescentrum Utrecht (1995).
86. Leuw, E. and Marshall, I.H. (eds)., Between
Prohibition and Legalization: The Dutch Experiment in Drug Policy,
Amsterdam: Kugler Publications (1994).
87. Netherlands Institute for Alcohol and Drugs,
"Cannabis Policy Fact Sheet," Netherlands Alcohol and Drug Report
1 (1995); Leuw, E., "Initial Construction and Development of the
Official Dutch Drug Policy," pp 23-40 in E. Leuw and I.H. Marshall (eds),
Between Prohibition and Legalization: The Dutch Experiment in Drug Policy,
Amsterdam: Kugler Publications (1994).
88. de Zwart, W.M. et al, Key Data: Smoking, Drinking,
Drug Use and Gambling Among Pupils Aged 10 Years and Older, Utrecht:
Netherlands Institute on Alcohol and Drugs (1994).
89.National Household Survey on Drug Abuse: Main Findings 1990, Rockville,
MD: National Institute on Drug Abuse (1991); Preliminary Estimates from the
1993 Household Survey on Drug Abuse, Advance Report Number 7, Rockville,
MD: National Institute on Drug Abuse (1994).
90. National Survey Results on Drug Use, from the
Monitoring the Future Study, 1975-1993, Volume I, Rockville, MD: National
Institute on Drug Abuse (1994).
91. de Zwart, W.M. et al, Key Data: Smoking, Drinking,
Drug Use and Gambling Among Pupils Aged 10 Years and Older, Utrecht:
Netherlands Institute on Alcohol and Drugs (1994).
92. "The Drug Policy in the Netherlands," Joint
Report of the Ministry of Welfare, Health and Cultural Affairs and the Ministry
of Justice (1994).
|
カナビス神話を暴く １９９５
参考文献一覧